Eutilex is developing anticancer T cell and antibody therapeutics based on innovative immunotherapeutic technology, and aims to be a leader in anti-cancer immunotherapeutics market through technological innovation and early commercialization. was established to treat incurable diseases such as cancer and autoimmune diseases without side effects by developing new immunotherapeutic agents and promoting commercialization as the c...
Eutilex is developing anticancer T cell and antibody therapeutics based on innovative immunotherapeutic technology, and aims to be a leader in anti-cancer immunotherapeutics market through technological innovation and early commercialization. was established to treat incurable diseases such as cancer and autoimmune diseases without side effects by developing new immunotherapeutic agents and promoting commercialization as the company name expresses. The core competence of the utility is its ability to selectively boost and inhibit immune function and target screening capabilities.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.